logo

Novo Nordisk ADR (NVO) Stock: A Year of Market Movement, Down and Up

ALXO Stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Novo Nordisk ADR’s current trading price is -38.63% away from its 52-week high, while its distance from the 52-week low is 16.84%. The stock’s price range over this period has fluctuated between $77.82 and $148.15. The company, operating within the financial sector, had a trading volume of approximately 3.02 million for the day, which was noticeably lower than the average daily share volume of 8.87 million over the last 3 months.

Novo Nordisk ADR ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $148.15 on 06/25/24, while the lowest value for the same period was recorded at $77.82 on 02/14/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Novo Nordisk ADR (NVO) has experienced a quarterly decline of -14.86% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 305.89B and boasts a workforce of 76302 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 97.92, with a change in price of -25.80. Similarly, Novo Nordisk ADR recorded 7,409,283 in trading volume during the last 100 days, posting a change of -22.01%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for NVO stands at 0.72. Similarly, the long-term debt-to-equity ratio is also 0.62.

NVO Stock Stochastic Average

Today, Novo Nordisk ADR’s raw stochastic average for the past 50 days stands at 50.43%, indicating a decline from the raw stochastic average of the last 20 days, which was 84.98%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 72.61% and 72.76% respectively.

NVO Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price gain of 5.70% this year. Over the last six months, there has been a stronger performance of -34.66%. The price of NVO fallen by 10.01% during the last 30 days period. For the last 5-days stocks have improved 1.54%.

Most Popular